Innovative Miami Firm Secures Patent for Groundbreaking Technology
Miami's Longeveron Inc. has received a U.S. patent allowance for its revolutionary regenerative medicine product, Lomecel-B™, impacting future treatments.
Miami's Longeveron Inc. has received a U.S. patent allowance for its revolutionary regenerative medicine product, Lomecel-B™, impacting future treatments.